PAPPA2 and preeclampsia: In conclusion, in a prospective cohort suspected of preeclampsia development, the angiogenic modulators sFlt‐1 and PlGF; the renal function markers BUN, Cre, UA, and Cysc; and the glycoprotein PAPP‐A2 were significantly altered between the two groups.